全文获取类型
收费全文 | 337731篇 |
免费 | 23107篇 |
国内免费 | 7300篇 |
专业分类
耳鼻咽喉 | 4253篇 |
儿科学 | 9690篇 |
妇产科学 | 6555篇 |
基础医学 | 27641篇 |
口腔科学 | 8064篇 |
临床医学 | 36804篇 |
内科学 | 42382篇 |
皮肤病学 | 4610篇 |
神经病学 | 19373篇 |
特种医学 | 7883篇 |
外国民族医学 | 31篇 |
外科学 | 36334篇 |
综合类 | 50662篇 |
现状与发展 | 12篇 |
一般理论 | 29篇 |
预防医学 | 34154篇 |
眼科学 | 5235篇 |
药学 | 30135篇 |
373篇 | |
中国医学 | 30519篇 |
肿瘤学 | 13399篇 |
出版年
2023年 | 5222篇 |
2022年 | 7790篇 |
2021年 | 12573篇 |
2020年 | 12368篇 |
2019年 | 18343篇 |
2018年 | 16095篇 |
2017年 | 12828篇 |
2016年 | 10270篇 |
2015年 | 9597篇 |
2014年 | 19907篇 |
2013年 | 21369篇 |
2012年 | 18229篇 |
2011年 | 19704篇 |
2010年 | 15839篇 |
2009年 | 14506篇 |
2008年 | 14139篇 |
2007年 | 14661篇 |
2006年 | 12732篇 |
2005年 | 11066篇 |
2004年 | 9040篇 |
2003年 | 7991篇 |
2002年 | 6228篇 |
2001年 | 5621篇 |
2000年 | 4609篇 |
1999年 | 3973篇 |
1998年 | 3037篇 |
1997年 | 2896篇 |
1996年 | 2507篇 |
1995年 | 2586篇 |
1994年 | 2502篇 |
1993年 | 2006篇 |
1992年 | 2022篇 |
1991年 | 1761篇 |
1990年 | 1564篇 |
1989年 | 1389篇 |
1988年 | 1314篇 |
1987年 | 1148篇 |
1985年 | 3807篇 |
1984年 | 4841篇 |
1983年 | 3373篇 |
1982年 | 3848篇 |
1981年 | 3581篇 |
1980年 | 3196篇 |
1979年 | 2926篇 |
1978年 | 2550篇 |
1977年 | 1923篇 |
1976年 | 2167篇 |
1975年 | 1644篇 |
1974年 | 1434篇 |
1973年 | 1282篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Nicolas Penel Sylvie Bonvalot Marie-Cécile Le Deley Antoine Italiano Camille Tlemsani Diane Pannier Clémence Leguillette Jean-Emmanuel Kurtz Maud Toulmonde Julien Thery Daniel Orbach Pascale Dubray-Longeras Benjamin Verret François Bertucci Cécile Guillemet Lucie Laroche Armelle Dufresne Jean-Yves Blay Axel Le Cesne 《International journal of cancer. Journal international du cancer》2023,153(2):407-416
The aim of this study is to evaluate the prevalence, determinants and prognostic value of pain at diagnosis in patients with desmoid-type fibromatosis (DF). We selected patients from the ALTITUDES cohort (NCT02867033), managed by surgery, active surveillance or systemic treatments, with pain assessment at diagnosis. Patients were invited to fill QLQ-C30 questionnaire and Hospital Anxiety Depression Scale. Determinants were identified using logistic models. Prognostic value on event-free survival (EFS) was evaluated using the Cox model. Overall, 382 patients were included in the current study (median age: 40.2 years; 117 men). The prevalence of pain was 36%, without significant difference according to first-line treatment (P = .18). In the multivariate analysis, pain was significantly associated with tumor size >50 mm (P = .013) and tumor site (P < .001); pain was more frequent in the neck and shoulder locations (odds ratio: 3.05 [1.27-7.29]). Pain at baseline was significantly associated with poor quality of life (P < .001), depression (P = .02), lower performance status (P = .03) and functional impairment (P = .001); we also observed a nonsignificant association with anxiety (P = .10). In the univariate analysis, baseline pain was associated with poor EFS; the 3-year EFS was 54% in patients with pain compared to 72% in those without pain. After adjustment for sex, age, size and line of treatment, pain was still associated with poor EFS (hazard ratio: 1.82 [1.23-2.68], P = .003). One third of recently diagnosed patients with DF experienced pain, especially those with larger tumors and neck/shoulder locations. Pain was associated with unfavorable EFS after adjustment for the confounders. 相似文献
62.
63.
64.
《Revista portuguesa de cardiologia》2022,41(3):253-259
Left ventricular noncompaction (LVNC) is a genetically heterogeneous cardiomyopathy, with familial and sporadic forms, but genetic testing only identifies a pathogenic mutation in a minority of cases. The main complications are heart failure, embolism and dysrhythmias. Herein we report a familial case of LVNC associated with a mutation in the MYH7 gene and review the literature regarding controversies in LVNC. A 50-year-old woman was referred to the cardiology clinic for palpitations. She underwent echocardiography and cardiac magnetic resonance imaging that revealed mild left ventricular systolic dysfunction and LVNC criteria. She had several episodes of non-sustained ventricular tachycardia and received an implantable cardioverter-defibrillator (ICD). Genetic testing revealed the c.1003G>C (p.Ala335Pro) mutation in the MYH7 gene. Familial screening showed clear genotype-phenotype cosegregation, which provided strong evidence for the pathogenic role of this mutation. To the best of our knowledge, this is the first report of LVNC associated with the p.Ala335Pro mutation in the MYH7 gene. This mutation has been described in hypertrophic cardiomyopathy, suggesting that the same pathogenic sarcomere mutation may be associated with different cardiomyopathies. This case also highlights the current difficulties regarding decisions on ICD implantation for primary prevention of sudden cardiac death in LVNC. 相似文献
65.
66.
67.
PurposeGlioblastoma multiforme (GBM) is the most common malignant brain tumor. Moreover, GBM recurs in nearly all patients. Although a standard STUPP protocol has been widely used for newly diagnosed GBM, no standard regimen has been established for recurrent patients. Here we evaluated the clinical value of recurrent GBM reoperation by comparing overall survival and quality of life (QoL) in patients with recurrent GBM undergoing repeat surgery or conservative treatment.MethodsThis was a prospective study of 165 patients with GBM receiving first operations for their disease between 2011 and 2013 at two tertiary neurosurgery centers in Poland. Thirty-five eligible patients were re-operated for recurrence (the study group), and 35 patients were selected as the control group using propensity score matching. A model was created to determine advantageous prognostic factors for longer survival of patients qualifying for reoperation using stepwise linear regression.ResultsThe mean overall survival of patients undergoing repeat surgery was 528 days compared to 297 days in patients who did not undergo repeat surgery. Reoperation did not result in a significant deterioration in performance status as measured by the Karnofsky Performance Scale. Older age, the presence of symptoms of increased intracranial pressure, and a shorter period between initial operation and reoperation were independent predictors of a worse outcome.ConclusionIn selected patients, reoperation for recurrent GBM prolongs survival with no significant deteriorations in performance status. 相似文献
68.
《Clinical breast cancer》2022,22(6):507-514
Breast cancer (BC) is a highly metastatic, pathological cancer that significantly affects women worldwide. The mortality rate of BC is related to its heterogeneity, aggressive phenotype, and metastasis. Recent studies have highlighted that the tumor microenvironment (TME) is critical for the interplay between metastasis mediators in BC. BC stem cells, tumor-derived exosomes, circulatory tumor cells (CTCs), and signaling pathways dynamically remodel the TME and promote metastasis. This review examines the cellular and molecular mechanisms governing the epithelial to mesenchymal transition (EMT) that facilitate metastasis. This review also discusses the role of cancer stem cells (CSCs), tumor-derived exosomes, and CTs in promoting BC metastasis. Furthermore, the review emphasizes major signaling pathways that mediate metastasis in BC. Finally, the interplay among CSCs, exosomes, and CTCs in mediating metastasis have been highlighted. Therefore, understanding the molecular cues that mediate the association of CSCs, exosomes, and CTCs in TME helps to optimize systemic therapy to target metastatic BC. 相似文献
69.
70.